2 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
Follow No adjuvant therapy: new trials by email Literature Review of No adjuvant therapy trials Research Report on No adjuvant therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022) Osimertinib, No adjuvant therapy - Lung Cancer, EGFR Gene Mutation | Phase 3 | Not yet recruiting | Fudan University | 226 | 2024-04-01 | 2024-03-21 |
| The Construction and Validation of a Risk Prediction Model for Perioperative Hypoglycemia in Digestive Endoscopy No adjuvant therapy - Hypoglycemia | Completed | Ningbo No. 1 Hospital | 4 | 2024-01-01 | 2025-08-20 | |
| Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy No adjuvant therapy, Adjuvant radiotherapy - Cervical Cancer | Phase 3 | Recruiting | The Central and Eastern European Gynecologic Oncology Group | 514 | 2022-06-10 | 2023-09-07 |
| Treatment Protocol for Non-Metastatic Unilateral Retinoblastoma Combination Chemotherapy plus Intrathecal Topotecan, Higher Dose Combination Chemotherapy plus Intrathecal Topotecan, Higher Dose Combination Chemotherapy plus Intrathecal Topotecan and Orbital Radiotherapy - Unilateral Retinoblastoma | Phase 3 | Completed | Hospital JP Garrahan | 84 | 2018-01-01 | 2025-04-13 |
Hypoglycemia (1) · Lung Neoplasms (1) · Neoplasm, Residual (1) · Uterine Cervical Neoplasms (1)
Fudan University (1) · Hospital JP Garrahan (1) · Ningbo No. 1 Hospital (1) · The Central and Eastern European Gynecologic Oncology Group (1)
Argentina (1) · China (1) · Czechia (1)